The White House
Blade speaks exclusively to U.S. envoy for global LGBTQ rights
Jessica Stern named to position in June 2021
The special U.S. envoy for the promotion of LGBTQ rights abroad in an exclusive interview with the Washington Blade ahead of Pride month highlighted the White House’s efforts in support of LGBTQ rights around the world.
Jessica Stern pointed out to the Blade the State Department’s decision to offer passports with an “X” gender marker “is an important example of how we’re expanding resources to people who are targeted because of gender identity and expression.” She also noted U.S. embassies and consulates over the last year have publicly condemned violence based on sexual orientation and gender identity.
Andrea González, a transgender activist in Guatemala who was shot to death on June 11, 2021, near her Guatemala City home, participated in the State Department’s International Visitors Leadership Program.
Assistant Secretary of State for Western Hemisphere Affairs Brian Nichols is among the U.S. officials who condemned González’s murder. William Popp, the U.S. ambassador to Guatemala, and U.S. Agency for International Development Administrator Samantha Power visited the headquarters of González’s group, Reinas de la Noche, to express their condolences over her death.
The U.S. Consulate General in Erbil, the capital of Iraqi Kurdistan, condemned the so-called honor killing of Doski Azad, a trans woman whose brother reportedly shot her in the head and chest in January after she returned to the region. The State Department in May 2021 in a statement to the Blade described the so-called honor killing of Ali Fazeli Monfared, an Iranian man whose relatives murdered him after they learned he was gay, as “appalling.”
Stern noted the Biden administration’s continued support of LGBTQ rights abroad also includes marriage equality in countries where activists say such a thing is possible through legislation or the judicial process.
“The administration acknowledges that married or not, LGBTQI+ people, couples and their families deserve full equality, access to legal protections and should have their families legally recognized,” she said. “All of this is consistent with President Biden’s commitment to LGBTQI+ equality and marriage equality specifically.”
President Biden in February 2021 signed a memo that committed the U.S. to promoting LGBTQ rights abroad as part of his administration’s overall foreign policy. The White House four months later named Stern, who was previously the executive director of OutRight Action International, as the next special U.S. envoy for the promotion of LGBTQ rights abroad.
Biden, who is Catholic, was vice president in 2012 when he publicly backed marriage equality during on NBC’s “Meet the Press.” He spoke in favor of the issue before then-President Obama did.
A law that allows same-sex couples to marry and adopt children took effect in Chile in March.
Same-sex couples in Switzerland will be able to legally on July 1 after voters last November overwhelmingly approved a “Marriage for All” law.
Lawmakers in Cuba continue to consider a new family code that could pave the way for marriage equality on the island. Honduran President Xiomara Castro, who took office in January, has publicly backed marriage equality in her country.
The Privy Council’s Judicial Committee in London in March upheld a Bermuda law that rescinded marriage rights for same-sex couples. The same judicial body, which is an appellate court for British territories, also ruled same-sex couples don’t have a constitutional right to marry in the Cayman Islands.
Stern last month spoke at the 2022 ILGA World Conference that took place in Long Beach, Calif.
She spoke with the Blade before she traveled to Malaysia, Thailand, Vietnam. Stern will also visit Lithuania, Sweden and the Netherlands before she returns to the U.S. on June 8.
Malaysia is one of the upwards of 70 countries in which consensual same-sex sexual relations remain criminalized. Iran, Saudi Arabia and Mauritania are three of the handful of nations in which homosexuality remains punished by death.
State Department spokesperson Ned Price, who is openly gay, during a May 2021 interview with the Blade said the decriminalization of consensual same-sex sexual relations is one of the Biden administration’s five priorities in its efforts to promote LGBTQ rights abroad. Stern noted that “among a wider set of priorities, marriage equality is one element of our longstanding and ongoing commitment to advance the rights of LGBTQI+ persons.”
“All human beings should be treated with respect and dignity and should be able to live without fear, regardless of who they love,” she said.
Stern acknowledged potential critics of the White House’s efforts to champion marriage equality and other LGBTQ-specific issues around the world. Stern stressed, however, the “only thing that holds us back is hatred and intolerance.”
“We see autocracy is on the rise globally. We see that democratic institutions and democracies themselves are being undermined and we see LGBTQI+ people are often the canary in the coal mine,” she said. “We need to fight back against these homophobic and transphobic trends.”
The State Department on April 28 released a report on the implementation of Biden’s memo.
USAID and the President’s Emergency Plan for AIDS Relief a few weeks earlier announced they delivered more than 18 million doses of antiretroviral drugs for Ukrainians with HIV/AIDS. Ukrainian President Volodymyr Zelenskyy last August after he met with Biden at the White House pledged his country will continue to fight anti-LGBTQ discrimination.
Stern noted Canada and Germany are among the other countries that have pledged to support LGBTQ rights abroad as part of their respective foreign policies.
“Every administration sets its own priorities. We know what a positive impact President Biden’s staunch support of LGBTQI+ rights has had on this community domestically and on our support for LGBTQI+ people internationally,” she said. “Thankfully, governments around the world are increasingly normalizing the idea that LGBTQI+ people are entitled to recognition under the law and affirming that their rights need to be an explicit part of a human rights agenda.”
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
The White House
Empty seats, canceled shows plague Kennedy Center ahead of Trump renaming
It would take an act of Congress to officially rename the historic music venue, despite the Trump-appointed board’s decision.
The board of the Kennedy Center in Washington, D.C., voted to rename it the Trump-Kennedy Center, according to the White House Press Office.
White House Press Secretary Karoline Leavitt announced the decision in a post on X Thursday, thanking the president for his work on the cultural center “not only from the standpoint of its reconstruction, but also financially, and its reputation.”
Speaking to reporters later that day at the White House, Trump said he was “surprised” and “honored” by the board’s vote.
“This was brought up by one of the very distinguished board members, and they voted on it, and there’s a lot of board members, and they voted unanimously. So I was very honored,” he said.
Earlier this year, GOP Rep. Mike Simpson of Idaho introduced an amendment that would have renamed the building after first lady Melania Trump, later saying she had not been aware of his efforts prior to the amendment’s public introduction.
Despite the board’s vote (made up of Trump-appointed loyalists), the original laws guiding the creation of the Kennedy Center during the Eisenhower, Kennedy, and Johnson administrations explicitly prohibit renaming the building. Any change to its name would require an act of Congress.
Trump has exerted increasing control over the center in recent months. In February, he abruptly fired members of the Kennedy Center’s board and installed himself as chair, writing in a Truth Social post at the time, “At my direction, we are going to make the Kennedy Center in Washington D.C., GREAT AGAIN.”
In that post, Trump specifically cited his disapproval of the center’s decision to host drag shows.
He later secured more than $250 million from the Republican-controlled Congress for renovations to the building.
Since Trump’s takeover, sales of subscription packages are said to have declined, and several touring productions — including “Hamilton” — have canceled planned runs at the venue. Rows of empty seats have also been visible in the Concert Hall during performances by the National Symphony Orchestra.
“The Kennedy Center Board has no authority to actually rename the Kennedy Center in the absence of legislative action,” House Minority Leader Hakeem Jeffries told reporters.
For decades, the Kennedy Center has hosted performances by LGBTQ artists and companies, including openly queer musicians, choreographers, and playwrights whose work helped push LGBTQ stories into the cultural mainstream. Those artists include the Gay Men’s Chorus of Washington, Harvey Fierstein, and Tennessee Williams.
In more recent years, the center has increasingly served as a space for LGBTQ visibility and acceptance, particularly through Pride-adjacent programming and partnerships.
That legacy was on display at this year’s opening production of Les Misérables, when four drag performers — Tara Hoot, Vagenesis, Mari Con Carne, and King Ricky Rosé — attended in representation of Qommittee, a volunteer network uniting drag artists to support and defend one another amid growing conservative attacks.
“We walked in together so we would have an opportunity to get a response,” said Tara Hoot, who has performed at the Kennedy Center in full drag before. “It was all applause, cheers, and whistles, and remarkably it was half empty. I think that was season ticket holders kind of making their message in a different way.”
The creation of the Kennedy Center is outlined in U.S. Code, which formally designates the institution as the John F. Kennedy Center for the Performing Arts.
As a result, it appears unlikely that Congress will come together to pass legislation allowing the historic venue to be renamed.
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
